SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001178913-17-000566
Filing Date
2017-02-21
Accepted
2017-02-21 06:09:58
Documents
1
Group Members
TAMARKIN MEDICAL INNOVATIONS LTD.

Document Format Files

Seq Description Document Type Size
1 SC 13G/A zk1719593.htm SC 13G/A 77166
  Complete submission text file 0001178913-17-000566.txt   78584
Mailing Address 2 HOLZMAN ST. WEIZMANN SCIENCE PARK REHOVOT L3 76704
Business Address 2 HOLZMAN ST. WEIZMANN SCIENCE PARK REHOVOT L3 76704 97289316233
Foamix Pharmaceuticals Ltd. (Subject) CIK: 0001606645 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88525 | Film No.: 17623281
SIC: 2833 Medicinal Chemicals & Botanical Products

Mailing Address 537 HAR HILA ST. MODIIN-MACCABIM-REUT L3 7179901
Business Address
Tamarkin Dov (Filed by) CIK: 0001631962 (see all company filings)

Type: SC 13G/A